CrushSCI.com
88.3Average days
84Median days
54Fastest days
169Longest days
6552025 publications

Paper Review Records

All Paper Review Records

15 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

77 days

Association of the IASLC histologic grading system with aggressive pathologic features in invasive non-mucinous lung adenocarcinoma

Authors
Herui Han; Zirui Zhu; Jie Gao; Yiming Liu; Mingchuan Hu; Xiangming Qiu; Xizhe Zhang; Yuan Liu; Wenjin Pan; Xinran Tian; Xinyang Li; Zhiqiang XueShow moreShow less
Affiliations
Medical School of Chinese PLA, Beijing 100853, China; Department of Thoracic Surgery, the First Medical Centre, Chinese PLA General Hospital, Beijing 100853, China; Department of Pathology, the First Medical Centre, Chinese PLA General Hospital, Beijing 100853, China; School of Medicine, Nankai University, Tianjin 300071, ChinaShow moreShow less
Source PDF DOI Publisher page
64 days

Integrated histopathological, immunohistochemical, and molecular profiling reveals hidden heterogeneity within histologic subtypes of thymoma

Authors
Yi-Chen Yeh; Min-Shu Hsieh; Lei-Chi Wang; Ping-Yuan Chu; Yu-Chao Wang; Po-Kuei HsuShow moreShow less
Affiliations
Department of Pathology and Laboratory Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan; Graduate Institute of Pathology, National Taiwan University College of Medicine, Taipei, Taiwan; Department of Pathology, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan; Institute of Biomedical Informatics, National Yang Ming Chiao Tung University, Taipei, Taiwan; Digital Medicine and Smart Healthcare Research Center, National Yang Ming Chiao Tung University, Taipei, Taiwan; Division of Thoracic Surgery, Department of Surgery, Taipei Veterans General Hospital, Taipei, Taiwan; Department of Surgery, School of Medicine, National Yang Ming Chiao Tung University, Taipei, TaiwanShow moreShow less
Source PDF DOI Publisher page
74 days

From whole-exome sequencing to functional insight: Characterization of rare germline variants in lung cancer

Authors
Simone Bonora; Maron Daw; Claudio Tabolacci; Alessio Cortellini; Fabrizio Citarella; Maria Luisa Scattoni; Loredaria Adamo; Anna Marabotti; Carla Lintas; Fiorella GurrieriShow moreShow less
Affiliations
Department of Chemistry and Biology “A. Zambelli”, University of Salerno, Via Giovanni Paolo II, 132, Fisciano, SA, 84084, Italy; Medical Genetics Laboratory, Department of Medicine and Surgery, University Campus Bio-Medico of Rome, Via Alvaro del Portillo 21, Roma, 00128, Italy; Operative Research Unit of Medical Genetics, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo 200, Roma, 00128, Italy; National Center for Rare Diseases, Istituto Superiore Di Sanità, Viale Regina Elena 299, Rome, 00161, Italy; Department of Medicine and Surgery, University Campus Bio-Medico of Rome, Via Alvaro del Portillo 21, Roma, 00128, Italy; Operative Research Unit of Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo 200, Roma, 00128, Italy; Department of Surgery and Cancer, Imperial College of London, Hammersmith Hospital Campus, Du Cane Road, London, UKShow moreShow less
Source PDF DOI Publisher page
110 days

Real-world effectiveness and safety of lurbinectedin in previously treated small cell lung cancer: results from Jazz EMERGE 402

Authors
Firas B. Badin; Philip E. Lammers; Geoffrey Liu; Leonid Shunyakov; Shaqil N. Kassam; Mehul P. Patel; Yan Ji; Catherine Labbé; Dennis Slater; Viral Rabara; Mehmood H. Hashmi; Shaker R. Dakhil; Matthias Weiss; John Migas; Alan C. Gowan; Nicole Bouchard; Paul Wheatley-Price; Samuel Nadeau; Badri Rengarajan; Raj Hanvesakul; Douglas S. Fuller; Balazs HalmosShow moreShow less
Affiliations
Baptist Health Medical Group, Lexington, KY, USA; Baptist Cancer Center, Memphis, TN, USA; Princess Margaret Cancer Centre, Toronto, ON, Canada; Carrie J. Babb Cancer Center, Bolivar, MO, USA; Southlake Regional Health Centre, Newmarket, ON, Canada; Rochester Regional Health, Rochester, NY, USA; HealthPartners Cancer Center at Regions Hospital, Saint Paul, MN, USA; Centre de Recherche de l’Institut Universitaire de Cardiologie et de Pneumologie de Québec, Université Laval, Québec City, QC, Canada; Eastern Connecticut Hematology and Oncology Associates, Norwich, CT, USA; Carolina Blood and Cancer Care Associates, Rock Hill, SC, USA; Stormont Vail Health, Topeka, KS, USA; Cancer Center of Kansas, Wichita, KS, USA; ThedaCare, Appleton, WI, USA; Mid-Illinois Hematology and Oncology Associates, Ltd., Normal, IL, USA; Baylor Scott & White Medical Center, Temple, TX, USA; Centre Hospitalier Universitaire de Sherbrooke, Université de Sherbrooke, Sherbrooke, QC, Canada; The Ottawa Hospital Cancer Centre, Ottawa, ON, Canada; Centre Intégré de Santé et de Services, Sociaux du Bas Saint-Laurent Hôpital, Rimouski, QC, Canada; Jazz Pharmaceuticals, Palo Alto, CA, USA; Jazz Pharmaceuticals, Oxford, England, UK; Jazz Pharmaceuticals, Philadelphia, PA, USA; Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USAShow moreShow less
Source PDF DOI Publisher page
107 days

Multicenter case series of pulmonary sclerosing pneumocytoma coinciding with typical carcinoid: Shared AKT1 p.E17K mutation in mixed-growth lesions

Authors
Weijie Chen; Yongtong Wang; Yue Wang; Runan Zhao; Zhengwei Dong; Yan Huang; Likun Hou; Chunyan Wu; Liye Zhang; Huikang XieShow moreShow less
Affiliations
Department of Pathology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China; School of Life Science and Technology, ShanghaiTech University, Shanghai 201210, China; Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, China; Department of Pathology, Changhai Hospital, Naval Military Medical University, Shanghai, China; Shanghai Clinical Research and Trial Center, Keyuan Road, Pudong New District, Shanghai 201210, ChinaShow moreShow less
Source PDF DOI Publisher page
169 days

Subtyping limited stage small cell lung cancer (LS SCLC) reveals inflammatory subtypes with improved chemoradiotherapy outcomes

Authors
Rafael Oliveira; Tarje Halvorsen; Kristin Killingberg; Elisabeth Fritzke Emdal; Vibeke Grotnes Dale; Bjørn Henning Grønberg; Pål SætromShow moreShow less
Affiliations
Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology (NTNU), Trondheim, Norway; Department of Oncology, St. Olavs Hospital HF, Trondheim University Hospital, Trondheim, Norway; Department of Pathology, St. Olavs Hospital HF, Trondheim University Hospital, Trondheim, Norway; Department of Computer Science, Norwegian University of Science and Technology (NTNU), Trondheim, Norway; St. Olavs Hospital HF, Central Staff, Trondheim University Hospital, Trondheim, NorwayShow moreShow less
Source PDF DOI Publisher page

FAQ

How long does LUNG CANCER take to review a manuscript?

As of 2026-11-13, CrushSCI has 15 complete review records for LUNG CANCER. The fastest paper went from submission to acceptance in 54 days (Environmental asbestos exposure and lung cancer burden compared with mesothelioma in rural Türkiye: A 33-Year population-based cohort study, received 2026-07-01, accepted 2026-08-24); the slowest took 169 days. The average is 88.3 days and the median is 84 days.

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.